Back

Trends of health care costs of heart failure during implementation of SGLT2 inhibitors: Data from Finnish nationwide registers

29 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Perspectives in public health and cardiovascular diseases (1) Health Economics ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Miikka Tarkia

Helsinki (Finland)

2 More presentations in this session

Presentation thumbnail
A global analysis of women's participation in cardiovascular clinical trials from 2018 to 2024
Miss A. Lee (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Patterns of treatment and genetic testing in transthyretin amyloid cardiomyopathy: a real-world, multinational survey
Miss J. Chung (US)
Abstract Slides Video

Access the full session

Session thumbnail
Perspectives in public health and cardiovascular diseases (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
A value-based analysis of the systematic use of dapagliflozin in patients with heart failure
thumbnail
Congress Presentation
Description of the profile of the patient with heart failure depending on the discharge service and the possible optimization of treatment with SGLT2i in a retrospective cohort from 2021 to 2022
thumbnail
Congress Presentation
Implementation of sodium-glucose co-transporter 2 inhibitors use in patients with heart failure across the ejection fraction: data from the Swedish heart failure registry

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources